Date
|
Speaker |
Department |
Title |
Sept. 01
|
Raymond B. Birge, PhD |
Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School Cancer Center |
Introduction to the course/
Innate apoptotic immunity |
Sept. 8 |
George Yap, PhD |
Medicine |
Host immune response to Toxoplasma gondii
|
Sept. 15
|
Pranela Rameshwar, PhD
|
Medicine: Stem Cell and Regenerative Medicine |
Mesenchymal stem cell therapies in cancer
|
Sept. 22 |
Carol Lutz, PhD |
Microbiology, Biochemistry, and Molecular Genetics |
Regulation of gene expression by small non-coding RNA
|
Sept. 29 |
Scott Kachlany, PhD |
Oral Biology |
A bacterial toxin as therapy |
Oct. 6 |
Amiriliz Rivera, PhD |
Center for Immunity and Inflammation |
Aspergillis and pulmonary fungal infections |
Oct. 13 |
Sheldon Lin MD |
Orthopaedics |
Cellular and biochemical mechanisms of bone fracture healing |
Oct. 20 |
Olga Boukrina, PhD |
Physical Medicine and Rehabilitation |
Language and Reading Deficits in Left-Hemisphere Stroke Survivors |
Oct. 27 |
Diego Fraidenraich, PhD |
Cell Biology and Molecular Medicine |
Connexin and muscular dystrophy-cardiomyopathy therapy |
Nov. 3 |
John Siekiera, PhD |
Center for Inflammation and Immunity/Montclair State University |
Lymphatic Filariasis and drug discovery |
Nov. 10 |
Marila Gennaro, PhD |
Epidemiology |
SARS-Cov-2 and COVID 19 testing in the pandemic |
Nov. 17 |
Dongfang Liu, PhD |
Pathology and Laboratory Medicine |
Chimeric Artificial T cells and Cancer Immunotherapy |
Nov. 24 |
Luciano D’Adamio, MD, PhD |
Department of Pharmacology, Physiology, and Neuroscience: Brain Health Institute |
Amyloid proteins, Alzheimer’s disease, and dementia |
Dec. 01 |
Joel S. Freundlich, Ph.D. |
Medicine: Rutgers Global Health Institute |
Artificial Intelligence: Engineering new platforms for the study of infectious diseases |
Dec. 8 |
Venkatesh Sundararajan |
Microbiology, Biochemistry, and Molecular Genetics
|
CODAS Syndrome and LONP1 mutations |